Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01655498 · ClinicalTrials.gov registry record · NA
A Clinical Evaluation of a Vaginal Bowel Control System for the Treatment of Fecal Incontinence in Women (LIFE)
A NA study, sponsored by Pelvalon.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT01655498: Completed NA study, sponsored by Pelvalon.
NCT01655498 is a NA study that has completed, run by Pelvalon. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01655498, a NA study, has completed, sponsored by Pelvalon.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The objective of this study is to obtain preliminary efficacy and safety data on the use of the LivSure System (now called the "Eclipse™ System") in women with fecal incontinence.
Primary Outcome
Subjects with at least a 50% reduction in FI episodes (major or minor soiling)
Interventions
- DEVICE vaginal bowel control system (LivSure)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-03 |
| Phase | NA |
What the finished NCT01655498 record still lists
NCT01655498 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which vaginal bowel control system (LivSure) is the first listed.
NCT01655498 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01655498 about?
NCT01655498 is a clinical study titled "A Clinical Evaluation of a Vaginal Bowel Control System for the Treatment of Fecal Incontinence in Women (LIFE)". The objective of this study is to obtain preliminary efficacy and safety data on the use of the LivSure System (now called the "Eclipse™ System") in women with fecal incontinence.
What is the current status of trial NCT01655498?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2012-08. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01655498?
The interventions under investigation include: vaginal bowel control system (LivSure) (DEVICE).
Who is sponsoring clinical trial NCT01655498?
This trial is sponsored by Pelvalon, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01655498's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia